The reporting of treatment nonadherence and its associated impact on economic evaluations conducted alongside randomized trials: A systematic review

Value in Health

Volumn 19, Issue 1, 2016, Pages 99-108

  Brilleman, Samuel L ^a   Metcalfe, Chris ^a   Peters, Tim J ^a   Hollingworth, William ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

adherence; compliance; economic evaluation; systematic review; trial

Indexed keywords

COST EFFECTIVENESS ANALYSIS; ECONOMIC EVALUATION; HEALTH CARE COST; HUMAN; INTENTION TO TREAT ANALYSIS; MEDICATION COMPLIANCE; MEDICATION NONCOMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; STATISTICAL ANALYSIS; SYSTEMATIC REVIEW; COST BENEFIT ANALYSIS; PROCEDURES; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA;

COST-BENEFIT ANALYSIS; DATA INTERPRETATION, STATISTICAL; HUMANS; MEDICATION ADHERENCE; MODELS, ECONOMETRIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84957839879     PISSN: 10983015     EISSN: 15244733     Source Type: Journal    
DOI: 10.1016/j.jval.2015.07.009     Document Type: Review

References (38)

1. S. Dodd, I.R. White, and P. Williamson Nonadherence to treatment protocol in published randomised controlled trials: a review Trials 13 2012 84
2. I. Cleemput, K. Kesteloot, and S. DeGeest A review of the literature on the economics of noncompliance: room for methodological improvement Health Policy 59 2002 65 94
3. D.A. Hughes, A. Bagust, A. Haycox, and T. Walley The impact of non-compliance on the cost-effectiveness of pharmaceuticals: a review of the literature Health Econ 10 2001 601 615
4. Z. Zhang, M.J. Peluso, C.P. Gross, and et al. Adherence reporting in randomized controlled trials Clin Trials 11 2014 195 204
5. D. Moher, S. Hopewell, K.F. Schulz, and et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials BMJ 340 2010 c869
6. A. Gandjour A model to transfer trial-based pharmacoeconomic analyses to clinical practice Pharmacoeconomics 29 2011 97 105
7. J. Nixon, B. Stoykova, J. Christie, and et al. NHS economic evaluation database for healthcare decision makers BMJ 321 2000 32
8. H. Strain Acute Health Clinical Costing Standards 2013/14 Healthcare Financial Management Association Bristol, UK 2013 Available from: http://www.hfma.org.uk/costing/standards/Previous+Years+Clinical+Costing+Standards/. [Accessed September 9, 2015]
9. L.H. Chuang, M.O. Soares, J.M. Watson, and et al. Economic evaluation of a randomized controlled trial of ultrasound therapy for hard-to-heal venous leg ulcers Br J Surg 98 2011 1099 1106
10. V. van der Meer, W.B. van den Hout, M.J. Bakker, and et al. Cost-effectiveness of Internet-based self-management compared with usual care in asthma PLoS One 6 2011 e27108
11. S. Wordsworth, J. Buchanan, J. Mollison, and et al. Clomifene citrate and intrauterine insemination as first-line treatments for unexplained infertility: are they cost-effective? Hum Reprod 26 2011 369 375
12. R.B. Hopkins, A.X. Garg, A. Levin, and et al. Cost-effectiveness analysis of a randomized trial comparing care models for chronic kidney disease Clin J Am Soc Nephrol 6 2011 1248 1257
13. E. Hedman, E. Andersson, B. Ljotsson, and et al. Cost-effectiveness of Internet-based cognitive behavior therapy vs. cognitive behavioral group therapy for social anxiety disorder: results from a randomized controlled trial Behav Res Ther 49 2011 729 736
14. L. Irvine, G.R. Barton, A.V. Gasper, and et al. Cost-effectiveness of a lifestyle intervention in preventing type 2 diabetes Int J Technol Assess 27 2011 275 282
15. N. Mittmann, P. Hernandez, C. Mellstrom, and et al. Cost effectiveness of budesonide/formoterol added to tiotropium bromide versus placebo added to tiotropium bromide in patients with chronic obstructive pulmonary disease: Australian, Canadian and Swedish healthcare perspectives Pharmacoeconomics 29 2011 403 414
16. A. Patel, E. Maissi, H.C. Chang, and et al. Motivational enhancement therapy with and without cognitive behaviour therapy for type 1 diabetes: economic evaluation from a randomized controlled trial Diabet Med 28 2011 470 479
17. S. Morris, T.P. Morris, A.H. McGregor, and et al. Function after spinal treatment, exercise, and rehabilitation: cost-effectiveness analysis based on a randomized controlled trial Spine (Phila Pa 1976) 36 2011 1807 1814
18. D.G.T. Whitehurst, S. Bryan, E.M. Hay, and et al. Cost-effectiveness of acupuncture care as an adjunct to exercise-based physical therapy for osteoarthritis of the knee Phys Ther 91 2011 630 641
19. M.E. van den Akker, M.P. Arts, W.B. van den Hout, and et al. Tubular diskectomy vs conventional microdiskectomy for the treatment of lumbar disk-related sciatica: cost utility analysis alongside a double-blind randomized controlled trial Neurosurgery 69 2011 829 836
20. K.S. Thomas, K. Koller, T. Dean, and et al. A multicentre randomised controlled trial and economic evaluation of ion-exchange water softeners for the treatment of eczema in children: the Softened Water Eczema Trial (SWET) Health Technol Assess 15 2011 1 156
21. S. Cockayne, M. Curran, G. Denby, and et al. EVerT: cryotherapy versus salicylic acid for the treatment of verrucae - a randomised controlled trial Health Technol Assess 15 2011 1 170
22. J. Gilden, A.B.P. Staring, M. van der Gaag, and C.L. Mulder Does treatment adherence therapy reduce expense of healthcare use in patients with psychotic disorders? Cost-minimization analysis in a randomized controlled trial Schizophr Res 133 2011 47 53
23. C. Glazener, C. Boachie, B. Buckley, and et al. Urinary incontinence in men after formal one-to-one pelvic-floor muscle training following radical prostatectomy or transurethral resection of the prostate (MAPS): two parallel randomised controlled trials Lancet 378 2011 328 337
24. K. Norman, M. Pirlich, C. Smoliner, and et al. Cost-effectiveness of a 3-month intervention with oral nutritional supplements in disease-related malnutrition: a randomised controlled pilot study Eur J Clin Nutr 65 2011 735 742
25. S. Palmer, and J. Raftery Economic notes: opportunity cost BMJ 318 1999 1551 1552
26. L. Gossec, F. Tubach, M. Dougados, and P. Ravaud Reporting of adherence to medication in recent randomized controlled trials of 6 chronic diseases: a systematic literature review Am J Med Sci 334 2007 248 254
27. D.A. Hughes, A. Bagust, A. Haycox, and T. Walley Accounting for noncompliance in pharmacoeconomic evaluations Pharmacoeconomics 19 2001 1185 1197
28. A. Kadambi, R.J. Leipold, A.R. Kansal, and et al. Inclusion of compliance and persistence in economic models: past, present and future Appl Health Econ Health Policy 10 2012 365 379
29. D. Hughes, W. Cowell, T. Koncz, and J. Cramer Methods for integrating medication compliance and persistence in pharmacoeconomic evaluations Value Health 10 2007 498 509
30. J.A. Cramer, A. Roy, A. Burrell, and et al. Medication compliance and persistence: terminology and definitions Value Health 11 2008 44 47
31. M.F. Drummond, M.J. Schulpher, G.W. Torrance, and et al. Methods for the Economic Evaluation of Health Care Programmes 3rd ed. 2005 Oxford University Press Oxford
32. D. Husereau, M. Drummond, S. Petrou, and et al. Consolidated Health Economic Evaluation Reporting Standards (CHEERS) - explanation and elaboration: a report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force Value Health 16 2013 231 250
33. U.S. Department of Health and Human Services, Food and Drug Administration. Guidance for industry: E9 statistical principles for clinical trials. 1998. Available from: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM073137.pdf. [Accessed September 8, 2014].
34. R.B. Haynes, E. Ackloo, N. Sahota, and et al. Interventions for enhancing medication adherence Cochrane Database Syst Rev 2008 CD000011
35. W.M. Macharia, G. Leon, B.H. Rowe, and et al. An overview of interventions to improve compliance with appointment keeping for medical services JAMA 267 1992 1813 1817
36. S.L. Bellamy, J.Y. Lin, and T.R. Ten Have An introduction to causal modeling in clinical trials Clin Trials 4 2007 58 73
37. J.D. Angrist, G.W. Imbens, and D.B. Rubin Identification of causal effects using instrumental variables J Am Stat Assoc 91 1996 444 455
38. S. Greenland An introduction to instrumental variables for epidemiologists Int J Epidemiol 29 2000 722 729